Flash e-reader

 Go to e-reader chapter








Table 14.10

De Novo Posttransplant Solid Malignancy, 2000 to 2009

Heart Recipients

Malignancies by Type Year of Transplant
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Total # of Post-Tx Malignancies 583 504 413 331 276 293 222 141 82 28
Squamous/Basal Cell Carcinoma 318 312 240 200 147 177 144 77 56 16
Melanoma 19 19 10 16 11 11 10 5 2 1
Kaposi Sarcoma - 1 - - - - 3 3 2 -
Central Nervous System 5 - - - - 1 3 - - -
Genito-Urinary (1) 82 58 50 47 49 40 32 17 5 2
Gastro-Intestinal (2) 34 19 23 19 9 8 10 9 3 2
Primary Hepatic Tumor 3 3 - 1 - 1 - 1 - -
Metastatic Hepatic Tumor 5 3 7 6 3 1 - - 1 -
Larynx/Bronchi/Lung 55 51 45 23 31 27 8 12 4 3
Breast/Thyroid 10 17 7 9 7 9 6 9 1 -
Leukemia 2 - 6 - 5 2 - - - 1
Sarcoma (3) 4 1 4 - 1 - - - - -
Other 41 18 21 8 12 15 4 7 8 3
Unknown 5 2 - 2 1 1 2 1 - -
Squamous/Basal Cell Carcinoma 54.5% 61.9% 58.1% 60.4% 53.3% 60.4% 64.9% 54.6% 68.3% 57.1%
Melanoma 3.3% 3.8% 2.4% 4.8% 4.0% 3.8% 4.5% 3.5% 2.4% 3.6%
Kaposi Sarcoma - 0.2% - - - - 1.4% 2.1% 2.4% -
Central Nervous System 0.9% - - - - 0.3% 1.4% - - -
Genito-Urinary (1) 14.1% 11.5% 12.1% 14.2% 17.8% 13.7% 14.4% 12.1% 6.1% 7.1%
Gastro-Intestinal (2) 5.8% 3.8% 5.6% 5.7% 3.3% 2.7% 4.5% 6.4% 3.7% 7.1%
Primary Hepatic Tumor 0.5% 0.6% - 0.3% - 0.3% - 0.7% - -
Metastatic Hepatic Tumor 0.9% 0.6% 1.7% 1.8% 1.1% 0.3% - - 1.2% -
Larynx/Bronchi/Lung 9.4% 10.1% 10.9% 6.9% 11.2% 9.2% 3.6% 8.5% 4.9% 10.7%
Breast/Thyroid 1.7% 3.4% 1.7% 2.7% 2.5% 3.1% 2.7% 6.4% 1.2% -
Leukemia 0.3% - 1.5% - 1.8% 0.7% - - - 3.6%
Sarcoma (3) 0.7% 0.2% 1.0% - 0.4% - - - - -
Other 7.0% 3.6% 5.1% 2.4% 4.3% 5.1% 1.8% 5.0% 9.8% 10.7%
Unknown 0.9% 0.4% - 0.6% 0.4% 0.3% 0.9% 0.7% - -
Total # of Patients 330 294 245 203 181 180 150 110 66 24


Source: OPTN/SRTR Data as of October 1, 2010.

(-) = None in category.

(1) Genito-Urinary: kidney, bladder, uterine cervix, uterine body, ovarian, vulva, testicular, prostate.

(2) Gastro-Intestinal: tongue, throat, esophagus, stomach, small intestine, colo-rectal, liver and biliary tract, pancreas.

(3) Sarcoma: fibrosarcoma, osteosarcoma, etc.

Recipient malignancy statistics are based on voluntary reporting to the OPTN.